• 448 Citations
  • 11 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Cossu Rocca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Head and Neck Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Organ Preservation Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 448 Citations
  • 11 h-Index
  • 54 Article
  • 2 Review article
  • 1 Comment/debate

Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

Depenni, R., Cossu Rocca, M., Ferrari, D., Azzarello, G., Baldessari, C., Alù, M., Nolé, F., Codecà, C., Boscolo, G., Piccininni, M., Cavalieri, S. & Bossi, P., Jul 2019, In : European Journal of Cancer. 115, p. 4-12 9 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Platinum
Residual Neoplasm
Drug Therapy
Disease-Free Survival

Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer

Orlandi, E., Miceli, R., Infante, G., Mirabile, A., Alterio, D., Cossu Rocca, M., Denaro, N., Vigna-Taglianti, R., Merlotti, A., Schindler, A., Pizzorni, N., Fallai, C., Licitra, L. & Bossi, P., Feb 15 2019, In : Dysphagia. 34, 1, p. 52-62 11 p.

Research output: Contribution to journalArticle

Oropharyngeal Neoplasms
Deglutition Disorders
Radiotherapy
Drug Therapy
Papillomaviridae

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Iacovelli, R., Cossu Rocca, M., Galli, L., Sabbatini, R., De Giorgi, U., Santini, D., Facchini, G., Mosca, A., Atzori, F., Zucali, P., Fornarini, G., Massari, F., Buti, S., Ricotta, R., Masini, C., Toscani, I., Biasco, E., Guida, A., Lolli, C., De Lisi, D. & 12 others, Rossetti, S., Terrone, C., Scartozzi, M., Miggiano, C., Pastorino, A., Bersanelli, M., Carlo-Stella, G., Pinto, C., Nobili, E., Nolè, F., Tortora, G. & Porta, C., 2018, In : Anti-Cancer Drugs. 29, 7, p. 705-709 5 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Disease-Free Survival
Survival
sunitinib
axitinib

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Iacovelli, R., Cossu Rocca, M., Galli, L., Sabbatini, R., De Giorgi, U., Santini, D., Facchini, G., Mosca, A., Atzori, F., Zucali, P., Fornarini, G., Massari, F., Buti, S., Ricotta, R., Masini, C., Toscani, I., Biasco, E., Guida, A., Lolli, C., De Lisi, D. & 12 others, Rossetti, S., Terrone, C., Scartozzi, M., Miggiano, C., Pastorino, A., Bersanelli, M., Carlo-Stella, G., Pinto, C., Nobili, E., Nolè, F., Tortora, G. & Porta, C., 2018, In : Anti-Cancer Drugs. 29, 7, p. 705-709 5 p.

Research output: Contribution to journalArticle

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Iacovelli, R., Cossu Rocca, M., Galli, L., Sabbatini, R., De Giorgi, U., Santini, D., Facchini, G., Mosca, A., Atzori, F., Zucali, P., Fornarini, G., Massari, F., Buti, S., Ricotta, R., Masini, C., Toscani, I., Biasco, E., Guida, A., Lolli, C., De Lisi, D. & 12 others, Rossetti, S., Terrone, C., Scartozzi, M., Miggiano, C., Pastorino, A., Bersanelli, M., Carlo-Stella, G., Pinto, C., Nobili, E., Nolè, F., Tortora, G. & Porta, C., 2018, In : Anti-Cancer Drugs. 29, 7, p. 705-709 5 p.

Research output: Contribution to journalArticle